The VRF Newsletter

Vitiligo research, treatments, people, policy — and the occasional story that makes us stop and say, wait, what?

We sort through the studies, clinical trials, regulatory news and community updates so you don’t have to. Then we put the useful bits into one readable email — usually with considerably less jargon than we started with.

Free to read. Independent by design. No paywall. No 47-page scientific paper required before breakfast. Just a regular snapshot of what is happening in vitiligo — and why it matters.

Previous Issues

Missed one? Start anywhere. Unlike most inboxes, this archive does not judge you for being three months behind.